CompoAtlas

OEMINE ARTRO HARPAGOPHYTUM CASSIS

Food supplement declared in France, declaration No 2023-1-1481, decision dated 27 January 2023

OEMINE ARTRO HARPAGOPHYTUM CASSIS, from PHYBIO PHARMA, is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Harpagophytum procumbens 960 mg per day, Ribes nigrum 270 mg per day. None of the rules we check flags an issue with its declared composition.

Brand
OEMINE
Food business operator placing the product on the market
PHYBIO PHARMA
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Capsule
Daily dose
3 gélules
Directions for use
1 gélule matin midi et soir
Objectives stated by the manufacturer (these are not authorised claims)
Joints

Declaration 308646, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Harpagophytum procumbensOrganes souterrainsExtrait sec aqueux960 mg
Ribes nigrum L.FeuilleExtrait sec aqueux270 mg

Additives

E551, E1204

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Photograph the packaging

Label warnings

Ce complément alimentaire ne doit pas être pris pendant la grossesse ni l'allaitement, ni par des personnes sousanti-inflammatoires ou anti-vitamine K. En cas de prise d'autres médicaments, demandez conseil à votre médecin ou àvotre pharmacien.

Regulatory points

None of the rules we check applies to the declared ingredients.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Harpagophytum procumbens
    Read the warning, when it applies and the studies cited

    DEVIL'S CLAW - HARPAGOPHYTUM

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Health Canada monograph dated 27 March 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Brand : OEMINE

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “OEMINE ARTRO HARPAGOPHYTUM CASSIS: composition and regulation”, https://compoatlas.com/en/supplements/products/308646-oemine-artro-harpagophytum-cassis, updated 15 November 2026.

List recorded in 2023. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line